X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Endokrynologia Polska

期刊標題檢索 ENDOKRYNOL POL 最新評論: Hello, I received an email titled "Reassessment after essential revis... (2024-02-14)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Endokrynologia Polska]您好,您是該頁面的第 14411 位訪客。

期刊簡介
期刊名稱Endokrynologia Polska Endokrynologia Polska
LetPub Score
4.7
50 ratings
Rate

Reputation
5.6

Influence
3.6

Speed
6.9

期刊簡稱ENDOKRYNOL POL
ISSN0423-104X
h-index24
CiteScore
CiteScoreSJRSNIPCiteScore Rank
2.600.3950.548
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Endocrinology, Diabetes and Metabolism
Q3162 / 244
Category: Medicine
Subcategory: Endocrinology
Q4101 / 128

自引率 (2023-2024)10.00%自引率趨勢
掲載範囲
"Endokrynologia Polska" publishes papers in English on all aspects of clinical and experimental endocrinology. The following types of papers may be submitted for publication: original articles, reviews, case reports, postgraduate education, letters to the Editor (Readers’ Forum) and announcements of scientific meetings, conferences and congresses.
官方網站https://journals.viamedica.pl/endokrynologia_polska
在線稿件提交https://journals.viamedica.pl/endokrynologia_polska/login?source=%2Fendokrynologia_polska%2Fuser%2FnewSubmission
開放訪問Yes
出版商Via Medica
主題領域ENDOCRINOLOGY & METABOLISM
出版國/地區POLAND
發行頻率隔月刊行
創刊年1950
每年文章數77每年文章數趨勢
黃金OA百分比99.55%
OA Related Info
APC: Yes( EUR615; )
APC waiver:No
Other charges: No
Keywords: therapy、hormones、secretion、endocrynology、metabolism、diabetes
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardDouble anonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ3134/186
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0423-104X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【Endokrynologia Polska】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640699
    BIOMATERIALS569574
    BIOMEDICINE & PHARMACOTHERAPY498326
    Frontiers in Pharmacology486593
    Journal of Materials Chemistry B476055
    JOURNAL OF ETHNOPHARMACOLOGY475694
    Frontiers in Immunology457846
    COLLOIDS AND SURFACES B-BIOINTERFACES419209
    COMPUTERS IN BIOLOGY AND MEDICINE416246
    Frontiers in Oncology413351
  •  

    Endokrynologia Polska Endokrynologia Polska
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Endokrynologia Polska] 的評論撰寫評論
作者: 努力啊大弘新


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-14 15:07:58 評論於
Hello, I received an email titled "Reassessment after essential revision", may I ask if it is a major revision or a minor one?
(0) 讚! | 努力啊大弘新

作者: 努力啊大弘新


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-14 10:00:16 評論於
Hello, is "rework" referring to major or minor repairs? What does "Reassessment after essential revision" mean?
(0) 讚! | 努力啊大弘新

作者: 破戒宇彤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-12 21:25:19 評論於
Layout fee 5000 yuan
(0) 讚! | 破戒宇彤

作者: 破戒宇彤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-30 19:42:26 評論於
Review speed: 1.0 | Submission success rate: 75.0
Focus research areas: Retina; Diabetic retinopathy
Experience sharing in diabetic retinopathy: Submitted on July 1, 2023, reviewed on July 3, and notified for revisions on July 31
(0) 讚! | 破戒宇彤

作者: 破戒宇彤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-27 19:06:13 評論於
Review Speed: 1.0 | Submission Hit Rate: 75.0
Emphasized Research Direction: Retina; Diabetic Retinopathy; Clinical Experience Sharing: Submitted on July 1, 2023, notified of revisions on July 31, with minimal changes made to the content, responded to reviewers' questions, revised on August 10, accepted on August 16, proof on October 11, published on October 23
(0) 讚! | 破戒宇彤

作者: 努力啊大弘新


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-17 22:24:11 評論於
Is "in review" for internal audit or external audit? How many stages does the entire review process go through?
(0) 讚! | 努力啊大弘新

作者: 玄清


領域: 医学
審稿時間: 3.0 month(s)
結果: 拒稿


撰寫評論

2023-07-11 15:20:47 評論於
At the beginning of the year, after submitting, it took about half a month for it to show "sent for external review". The review took about 3 months, but it was directly rejected without any reason provided! I sent an email to the editorial department, asking to see the review comments in order to make revisions, but I haven't received any response.
(0) 讚! | 玄清

作者: 一只振海呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-09 10:33:57 評論於
How much is the payment?
(0) 讚! | 一只振海呀

作者: 素伟三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-24 20:16:04 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0
Experience sharing: Submitted at the end of September 2022, received acceptance after two months of first review without major revisions. Acceptance rate among Chinese authors is okay, and rejections are also quite fast. Worth a try
(0) 讚! | 素伟三岁啦

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:56:24 評論於
The novelty of an article may be assessed through keyword searches
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 19:23:35 評論於
The main task of the introduction is to outline the basic content and structure of the whole article for the author. First, it is necessary to summarize the past and current situations in the field comprehensively, especially the latest advances and references to classic literature from the past. Analyze the limitations of past research and clarify the innovative points of your own research
(0) 讚! | 维尔娜菲茨杰拉德

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 08:13:02 評論於
How do reviewers use keywords to review?
(0) 讚! | 陶宜三岁啦

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 08:47:09 評論於
How to write an introduction?
(0) 讚! | 北国博达

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Endokrynologia Polska] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*